Vanguard Investments Australia
TECH icon

Vanguard Investments Australia’s Bio-Techne TECH Stock Holding History

Vanguard Investments Australia’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.86M Buy
40,484
+1,529
+4% +$82.6K 0.01% 770
2026
Q1 		$2.04M Buy
+38,955
New +$2.34M 0.01% 847

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Investments Australia's TECH Position: Q2 2026 in Review

Vanguard Investments Australia increased its Bio-Techne (TECH) stake by 3.9% in Q2 2026, buying an estimated $82.6K and bringing the position to 40,484 shares worth $2.86M. The position accounts for 0.01% of the portfolio, ranked #770.

Vanguard Investments Australia first reported a position in TECH in Q1 2026 and has held it in 2 quarters since. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Vanguard Investments Australia held 40,484 shares of Bio-Techne worth $2.86M as of Q2 2026.
  • Vanguard Investments Australia bought 1,529 Bio-Techne shares in Q2 2026, an estimated $82.6K.
  • Bio-Techne made up 0.01% of Vanguard Investments Australia's portfolio in Q2 2026, its #770 holding.
  • Vanguard Investments Australia first reported a position in Bio-Techne in Q1 2026 and has held it in 2 quarters since.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.